Genetically engineering small molecule therapeutics from fungi and plants to treat neuropsychiatric and neurologic disorders
We have built the first and only platform that makes it possible to genetically engineer neuroactive therapeutics from fungi and plants
Genetics and bioinformatics capabilities allow us to up-regulate and down-regulate genes and knock-out and knock-in genetic payloads to modify the neuroactive compounds that are created by fungi and plants.
Method for transformation and regeneration of fungi and plants, creating a pipeline of on-target compounds into human development.
GMP manufacturing process, enabling efficient expansion across other species and application to additional therapeutic areas.
Potential to discover novel small molecule therapeutics.